US Patent Issued to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION on Nov. 18 for "Immune adjuvant comprising hepatitis B virus-derived polypeptide" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,247, issued on Nov. 18, was assigned to SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (Seoul, South Korea).

"Immune adjuvant comprising hepatitis B virus-derived polypeptide" was invented by Bum Joon Kim (Seoul, South Korea), Byoung Jun Kim (Gyeonggi-do, South Korea), Yu Min Choi (Seoul, South Korea) and Hye In Jeong (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is an immune adjuvant including a polypeptide consisting of an amino acid sequence of SEQ ID NO: 2. The polypeptide is a hepatitis B virus-derived polypeptide, is effective in enhancing immunity through co-administration with vaccines as a single immune adjuvant, an...